HIV, hepatitis scare in US
29/2/2008 |
US officials say 40 000 people may have been infected with HIV and hepatitis in a major health scare after a Las Vegas clinic was found to have re-used syringes and medicine vials.
Read |
Laser could zap HIV
1/11/2007 |
A revolutionary laser technique can destroy viruses and bacteria such as AIDS without damaging human cells and may also help reduce the spread of hospital infections.
Read |
New anaemia drug delayed
22/5/2007 |
In the wake of the US FDA’s concern about the safety of anaemia drugs, the Swiss pharmaceutical firm Roche has announced the federal agency has delayed approving its drug, Mircera.
Read |
New anaemia med warnings
11/5/2007 |
A US FDA advisory panel has called for new warnings and additional safety studies on anaemia drugs commonly used to treat patients undergoing kidney dialysis or chemotherapy.
Read |
Shock as US docs take bribes
10/5/2007 |
US doctors are being paid millions of dollars a year by drug makers in return for prescribing anaemia medicines to patients that may be unsafe at commonly used doses.
Read |
Hep C ups cancer risk
9/5/2007 |
People with the liver disease hepatitis C face a higher risk of developing lymphoma, a cancer of the immune system, new research suggests.
Read |
Steroid vs. multiple myeloma
5/4/2007 |
Preliminary results from a study of patients with multiple myeloma found that a low dose of dexamethasone, in combination with lenalidomide, improved survival.
Read |
Green light for clotting med
2/4/2007 |
Ceprotin, a protein-based biologic drug that combats a rare clotting disorder, has been given government approval.
Read |
Anaemia meds under review
23/3/2007 |
The marketing and regulation of the commonly used anaemia drugs Epogen, Aranesp and Procrit are under review by a US Congressional committee.
Read |
Hope against blood disorder
19/3/2007 |
The US Food and Drug Administration have approved a first-of-its-kind drug to treat a rare blood disorder which can cause disability and premature death.
Read |
